Parvulet(R) Technology- Patient Centric Dosing Solution
Products
Information
Adare has recently launched a new patient centric dosage solution, the Parvulet TM Technology. The Parvulet TM Technology enables a solid powder or tablet to convert to a semi-solid in the presence of water within thirty seconds. The final dosage is easily administered, as a soft food like texture, ideal for pediatric and geriatric populations (including those with dysphagia).
Available In
North America (USA, Canada)Central America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
Supplied From
United States
Categories
Contract Services - Contract ServicesFormulation developmentPharmaceutical Machinery & TechnologyControlled, customized or modified drug release
